Invesco’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.83M | Buy |
|
|||||
|
2025
Q1 | $1.29M | Buy |
|
|||||
|
2024
Q4 | $502K | Buy |
|
|||||
|
2024
Q3 | $635K | Sell |
|
|||||
|
2024
Q2 | $7.18M | Buy |
|
|||||
|
2024
Q1 | $1.6M | Buy |
|
|||||
|
2023
Q4 | $1.39M | Sell |
|
|||||
|
2023
Q3 | $1.36M | Sell |
|
|||||
|
2023
Q2 | $5.17M | Buy |
|
|||||
|
2023
Q1 | $2.47M | Sell |
|
|||||
|
2022
Q4 | $3.33M | Buy |
|
|||||
|
2022
Q3 | $3.34M | Sell |
|
|||||
|
2022
Q2 | $2.82M | Sell |
|
|||||
|
2022
Q1 | $3.53M | Buy |
|
|||||
|
2021
Q4 | $2.48M | Sell |
|
|||||
|
2021
Q3 | $5.6M | Sell |
|
|||||
|
2021
Q2 | $31.6M | Sell |
|
|||||
|
2021
Q1 | $111M | Buy |
|
|||||
|
2020
Q4 | $128M | Sell |
|
|||||
|
2020
Q3 | $91.4M | Sell |
|
|||||
|
2020
Q2 | $72.3M | Sell |
|
|||||
|
2020
Q1 | $50.6M | Sell |
|
|||||
|
2019
Q4 | $146M | Buy |
|
|||||
|
2019
Q3 | $257M | Sell |
|
|||||
|
2019
Q2 | $370M | Buy |
|
|||||
|
2019
Q1 | $108M | Buy |
|
|||||
|
2018
Q4 | $60.8M | Buy |
|
|||||
|
2018
Q3 | $81.6M | Buy |
|
|||||
|
2018
Q2 | $53.3M | Buy |
|
|||||
|
2018
Q1 | $23.4M | Buy |
|
|||||
|
2017
Q4 | $7.9M | Sell |
|
|||||
|
2017
Q3 | $6.79M | Sell |
|
|||||
|
2017
Q2 | $8.75M | Sell |
|
|||||
|
2017
Q1 | $10.1M | Sell |
|
|||||
|
2016
Q4 | $7.67M | Buy |
|
|||||
|
2016
Q3 | $4.62M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.27M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $5K | Buy |
|